Research programme: diabetes therapy - Biovitrum

Drug Profile

Research programme: diabetes therapy - Biovitrum

Alternative Names: BVT 24834; BVT 3776; Diabetes therapy research programme - Biovitrum

Latest Information Update: 08 Sep 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Biovitrum
  • Class
  • Mechanism of Action Fatty acid-binding protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 08 Sep 2005 Discontinued - Preclinical for Type-2 diabetes mellitus in Sweden (unspecified route)
  • 07 Sep 2004 Preclinical trials in Type-2 diabetes mellitus in Sweden (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top